Skip to main content

Slaughter and May, Khaitan & Co and Nepalese firm Pioneer Law Associates have represented Malaysian power giant Tenaga Nasional Berhad on its purchase of a 30 percent stake in Indian conglomerate GMR Energy Ltd (GEL)’s portfolio of energy assets for $300 million.

White & Case acted for GEL, with partner Nandan Nelivigi handling the transaction. Cyril Amarchand Mangaldas and Krishnamurthy & Co advised GEL on India-related legal matters, with partners L Vishwanathan and Milind Jha overseeing the deal for their respective firms.  

The Slaughter and May team was led by partner David Watkins, while the Khaitan team included associate partner Akhil Bhatnagar and partners Dibyanshu and Avaantika Kakkar. with the Pioneer Law team was led by partner Anup Upreti.

GEL plans to use the proceeds from the sale to reduce its debt, which totalled $6.5 billion at the end of September. Meanwhile, the deal gives Tenaga – Malaysia’s biggest power utility company – stakes in GEL power plants that have a combined capacity of 4,630 MW. It also grants Tenaga the right to invest in other GEL assets including the Chhattisgarh project and Indonesian properties at any time within the next five years. Tenaga will also appoint executives in GMR’s senior management during the development and operation stage of projects included in the portfolio.

 

Related Articles

Cleary, A&O Shearman advise on Goodyear's $701 mln Dunlop sale

Cleary Gottlieb has advised tyremaker Goodyear Tire & Rubber Company on the $701 million sale of its Dunlop brand to Japan's Sumitomo Rubber Industries (SRI), which was represented by A&O Shearman.

Mori Hamada, Nagashima Ohno advise on $1.6 bln bid for Fujitsu General

Japanese law firms Mori Hamada & Matsumoto and Nagashima Ohno & Tsunematsu are playing key roles in Paloma Rheem Holdings' 257 billion yen ($1.6 billion) offer to acquire air conditioner manufacturer Fujitsu General.

CAM, Khaitan, Linklaters act on $355 mln Sai Life Sciences IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has driven the $355 million initial public offering of TPG-backed Indian healthcare R&D firm Sai Life Sciences, with Khaitan & Co and Linklaters advising the bookrunning lead managers. CAM has also acted for selling promoter shareholders Sai Quest Syn.